Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data.

OBJECT In this study, 1H magnetic resonance (MR) spectroscopy was prospectively tested as a reliable method for presurgical grading of neuroepithelial brain tumors. METHODS Using a database of tumor spectra obtained in patients with histologically confirmed diagnoses, 94 consecutive untreated patients were studied using single-voxel 1H spectroscopy (point-resolved spectroscopy; TE 135 msec, TE 135 msec, TR 1500 msec). A total of 90 tumor spectra obtained in patients with diagnostic 1H MR spectroscopy examinations were analyzed using commercially available software (MRUI/VARPRO) and classified using linear discriminant analysis as World Health Organization (WHO) Grade I/II, WHO Grade III, or WHO Grade IV lesions. In all cases, the classification results were matched with histopathological diagnoses that were made according to the WHO classification criteria after serial stereotactic biopsy procedures or open surgery. Histopathological studies revealed 30 Grade I/II tumors, 29 Grade III tumors, and 31 Grade IV tumors. The reliability of the histological diagnoses was validated considering a minimum postsurgical follow-up period of 12 months (range 12-37 months). Classifications based on spectroscopic data yielded 31 tumors in Grade I/II, 32 in Grade III, and 27 in Grade IV. Incorrect classifications included two Grade II tumors, one of which was identified as Grade III and one as Grade IV; two Grade III tumors identified as Grade II; two Grade III lesions identified as Grade IV; and six Grade IV tumors identified as Grade III. Furthermore, one glioblastoma (WHO Grade IV) was classified as WHO Grade I/II. This represents an overall success rate of 86%, and a 95% success rate in differentiating low-grade from high-grade tumors. CONCLUSIONS The authors conclude that in vivo 1H MR spectroscopy is a reliable technique for grading neuroepithelial brain tumors.

[1]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[2]  M O Leach,et al.  Introduction to in vivo MRS of cancer: new perspectives and open problems. , 1996, Anticancer research.

[3]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[4]  A R Tate,et al.  Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.

[5]  R. Somorjai,et al.  Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.

[6]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[7]  C B Begg,et al.  Statistical methods in medical diagnosis. , 1986, Critical reviews in medical informatics.

[8]  H Kalimo,et al.  MR classification of brain gliomas: value of magnetization transfer and conventional imaging. , 1995, Magnetic resonance imaging.

[9]  J. Voges,et al.  In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.

[10]  T. Hoshino.  A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. , 1984, Journal of neurosurgery.

[11]  P. Pantano,et al.  Supratentorial glioblastoma: Neuroradiological findings and survival after surgery and radiotherapy , 1996, Neuroradiology.

[12]  F. Podo,et al.  Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. , 1997, Acta neurochirurgica. Supplement.

[13]  E. Squillaci,et al.  MRI Atlas of Central Nervous System Tumors , 1991, Springer Vienna.

[14]  Mark Noble,et al.  Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.

[15]  J E Heiserman,et al.  Effect of voxel position on single-voxel MR spectroscopy findings. , 2000, AJNR. American journal of neuroradiology.

[16]  B. Ross,et al.  Short-Echo Time Proton MR Spectroscopy in the Presence of Gadolinium , 2001, Journal of computer assisted tomography.

[17]  M. Brant-Zawadzki.  Pitfalls of contrast‐enhanced imaging in the nervous system , 1991, Magnetic resonance in medicine.

[18]  J. K. Smith,et al.  Effects of contrast material on single-volume proton MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.

[19]  U. Nestle,et al.  A Review of Current and Future Treatment Strategies for Malignant Astrocytomas in Adults , 2000, Strahlentherapie und Onkologie.

[20]  E. Markakis,et al.  Quantitative proton magnetic resonance spectroscopy of focal brain lesions. , 2000, Pediatric neurology.

[21]  O. Schober,et al.  Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with123I-α-methyl tyrosine and PET with18F-deoxyglucose , 1997, European Journal of Nuclear Medicine.

[22]  I. Isherwood,et al.  Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain , 2004, Neuroradiology.

[23]  O. H. Lowry,et al.  DIVERSITY OF METABOLIC PATTERNS IN HUMAN BRAIN TUMORS—I. HIGH ENERGY PHOSPHATE COMPOUNDS AND BASIC COMPOSITION 1 , 1977, Journal of neurochemistry.

[24]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[25]  D. van Ormondt,et al.  SVD-based quantification of magnetic resonance signals , 1992 .

[26]  G. Chiro.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[27]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[28]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[29]  J. Ruíz-Cabello,et al.  Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.

[30]  D Matthaei,et al.  1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.

[31]  M Komiyama,et al.  MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. , 1987, AJNR. American journal of neuroradiology.

[32]  M Ala-Korpela,et al.  Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.

[33]  M. Décorps,et al.  High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. , 2001, Cancer research.

[34]  F. Podo.  Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[35]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[36]  E. Ryding,et al.  Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. , 1996, AJNR. American journal of neuroradiology.

[37]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[38]  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997 .

[39]  J R Griffiths,et al.  Classification of tumour 1H NMR spectra by pattern recognition , 1992, NMR in biomedicine.

[40]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[41]  L D Lunsford,et al.  Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.

[42]  J K Smith,et al.  Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.

[43]  O. Kizu,et al.  Evaluation of metabolic heterogeneity in brain tumors using 1H‐chemical shift imaging method , 1997, NMR in biomedicine.

[44]  C R Bird,et al.  Gliomas: classification with MR imaging. , 1990, Radiology.

[45]  J. Alger,et al.  High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy , 1989, Neurology.

[46]  J. Pettegrew,et al.  Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units , 1994, Neurobiology of Aging.

[47]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[48]  H. Shimizu,et al.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.

[49]  M. Thelen,et al.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.

[50]  Peter Russell,et al.  Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.

[51]  R. Wurm,et al.  Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas , 2001, European Radiology.

[52]  J A Frank,et al.  Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.

[53]  K. Herholz,et al.  Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. , 1995, Radiology.

[54]  E. Gotsis,et al.  In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. , 1996, Anticancer research.

[55]  J R Griffiths,et al.  An Investigation of Tumor 1H Nuclear Magnetic Resonance Spectra by the Application of Chemometric Techniques , 1992, Magnetic resonance in medicine.

[56]  R. Kauppinen,et al.  Choline‐Containing Compounds in Human Astrocytomas Studied by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of neurochemistry.